ESMO 2023 | Utilizing genomics and clinical data to personalize treatment options for patients with gliomas

Oriol Mirallas, MD, Vall d’Hebron Institute of Oncology, Barcelona, Spain, discusses the evolution of the way clinicians utilize genomics to further personalize approaches to treatment for patients with glioma. This interview took place at the European Society for Medical Oncology (ESMO) 2023 Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.